TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Development of a Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
Brief Summary: Development of Real-Time Antiretroviral Therapy Adherence Intervention in Uganda (The Wisepill Study).


Options:
A: Arm Label: Kilkari; Type: EXPERIMENTAL; Interventions: Other: Kilkari | Arm Label: Comparison; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Kilkari; Assigned to Arm(s): Kilkari
B: Arm Label: Fixed SMS, real-time monitoring; Type: EXPERIMENTAL; Interventions: Device: Fixed SMS, real-time monitoring | Arm Label: Triggered SMS, real-time monitoring; Type: EXPERIMENTAL; Interventions: Device: Triggered SMS, real-time monitoring | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Fixed SMS, real-time monitoring; Assigned to Arm(s): Fixed SMS, real-time monitoring | Intervention Type: DEVICE; Name: Triggered SMS, real-time monitoring; Assigned to Arm(s): Triggered SMS, real-time monitoring
C: Arm Label: Reminder module (SMS and Phone call); Type: EXPERIMENTAL; Interventions: Behavioral: Reminder module (SMS and Phone call) | Arm Label: Photovoice; Type: EXPERIMENTAL; Interventions: Behavioral: Photovoice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Reminder module (SMS and Phone call); Assigned to Arm(s): Reminder module (SMS and Phone call) | Intervention Type: BEHAVIORAL; Name: Photovoice; Assigned to Arm(s): Photovoice
D: Arm Label: SMS Reminder; Type: EXPERIMENTAL; Interventions: Other: SMS Reminder | Arm Label: Interactive Reminder; Type: EXPERIMENTAL; Interventions: Other: Interactive Reminder | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: SMS Reminder; Assigned to Arm(s): SMS Reminder | Intervention Type: OTHER; Name: Interactive Reminder; Assigned to Arm(s): Interactive Reminder

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intensified Insulin Treatment and Skin Microcirculation; Its Relation to Ischemic Foot Ulcer in Patients With Type 1 Diabetes Mellitus: A Long-term Follow-up Study
Brief Summary: We aim to investigate the relationship between skin microvascular function and the first hospitalization for ischemic foot ulcer in patients with type 1 diabetes former randomized during 7.5 years to intensified conventional insulin treatment (ICT) compared to standard insulin treatment (ST).


Options:
A: N/A
B: N/A
C: Arm Label: Intensified insulin treatment; Type: EXPERIMENTAL; Interventions: Drug: Intensified insulin treatment | Arm Label: Standard treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard treatment | Arm Label: Healthy controls; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Intensified insulin treatment; Assigned to Arm(s): Intensified insulin treatment | Intervention Type: DRUG; Name: Standard treatment; Assigned to Arm(s): Standard treatment
D: Intervention Type: BEHAVIORAL; Name: Insulin; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Healthy Living in Pregnancy
Brief Summary: Multicenter and multidisciplinary public health project in 10 regions of Bavaria, a federal state of Germany, targeting maternal and fetal health. The objective of this trial is to evaluate the efficacy of a lifestyle intervention program focusing on diet, physical activity and weight monitoring during pregnancy. The intervention comprises 4 individual counseling sessions addressing healthy living. Primary outcome: gestational weight gain. Secondary outcomes are pregnancy and obstetric complications like gestational diabetes and rate of caesarean sections as well as offspring health.

The lifestyle intervention program is adapted to the German health care system to allow an immediate implementation after successful evaluation.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention
B: Arm Label: Usual Care; Type: OTHER; Interventions: Other: Usual Care | Arm Label: Weight Management Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Weight Management | Intervention Type: BEHAVIORAL; Name: Weight Management; Assigned to Arm(s): Weight Management Counseling | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
C: Arm Label: Lifestyle and nutrition control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Lifestyle intervention group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lifestyle intervention group | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention group; Assigned to Arm(s): Lifestyle intervention group
D: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Lifestyle intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Healthy Living in Pregnancy
Brief Summary: Multicenter and multidisciplinary public health project in 10 regions of Bavaria, a federal state of Germany, targeting maternal and fetal health. The objective of this trial is to evaluate the efficacy of a lifestyle intervention program focusing on diet, physical activity and weight monitoring during pregnancy. The intervention comprises 4 individual counseling sessions addressing healthy living. Primary outcome: gestational weight gain. Secondary outcomes are pregnancy and obstetric complications like gestational diabetes and rate of caesarean sections as well as offspring health.

The lifestyle intervention program is adapted to the German health care system to allow an immediate implementation after successful evaluation.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention
B: Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise group | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise group; Assigned to Arm(s): Exercise group
C: Arm Label: Marinol; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Marinol D-40 | Arm Label: Nutrition counseling; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Marinol D-40; Assigned to Arm(s): Marinol
D: Arm Label: Lifestyle Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle Counseling | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle Counseling; Assigned to Arm(s): Lifestyle Counseling

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Outcomes in Neonatal Abstinence Syndrome
Brief Summary: 1: SPECIFIC Aim I: To compare treatment options for neonatal abstinence syndrome (NAS) due to in-utero narcotic exposure. One hundred eighty four full-term infants with a diagnosis of NAS requiring medications will be studied. Infants will be randomized to receive either morphine or methadone. It is hypothesized that morphine treated infants will do better and require fewer days in the hospital compared to methadone treated infants.

2. SPECIFIC Aim II: To evaluate the effects of NAS treatment on long-term neurodevelopmental outcome. Infants will be evaluated with development testing at 18 months of age. It is hypothesized that morphine treated infants will have better neurodevelopmental outcomes. It is also hypothesized that neurobehavioral abnormalities identified at two weeks of age will correlate with neurodevelopmental impairment at 18 months.

3: SPECIFIC Aim III: To determine if common genetic variations in the genes involving narcotic action contribute to the severity of NAS. A DNA sample will be obtained from all infants and analyzed for differences in 3 key genes. This will then be correlated with short-term and long-term outcomes.


Options:
A: Arm Label: Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone
B: Arm Label: Neonatal Morphine Solution; Type: ACTIVE_COMPARATOR; Interventions: Drug: Neonatal Morphine Solution, Drug: Phenobarbital | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone, Drug: Phenobarbital | Intervention Type: DRUG; Name: Neonatal Morphine Solution; Assigned to Arm(s): Neonatal Morphine Solution | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Phenobarbital; Assigned to Arm(s): Methadone, Neonatal Morphine Solution
C: Arm Label: 1 (Phenobarbital and Methadone); Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Arm Label: 2 (Phenobarbital and Diluted Deodorized Tincture of Opium); Type: ACTIVE_COMPARATOR; Interventions: Drug: Diluted Deodorized Tincture of Opium | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): 1 (Phenobarbital and Methadone) | Intervention Type: DRUG; Name: Diluted Deodorized Tincture of Opium; Assigned to Arm(s): 2 (Phenobarbital and Diluted Deodorized Tincture of Opium)
D: Arm Label: Low lactose formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Low lactose or regular formula | Arm Label: Regular formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Low lactose or regular formula | Intervention Type: OTHER; Name: Low lactose or regular formula; Assigned to Arm(s): Low lactose formula, Regular formula

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Outcomes in Neonatal Abstinence Syndrome
Brief Summary: 1: SPECIFIC Aim I: To compare treatment options for neonatal abstinence syndrome (NAS) due to in-utero narcotic exposure. One hundred eighty four full-term infants with a diagnosis of NAS requiring medications will be studied. Infants will be randomized to receive either morphine or methadone. It is hypothesized that morphine treated infants will do better and require fewer days in the hospital compared to methadone treated infants.

2. SPECIFIC Aim II: To evaluate the effects of NAS treatment on long-term neurodevelopmental outcome. Infants will be evaluated with development testing at 18 months of age. It is hypothesized that morphine treated infants will have better neurodevelopmental outcomes. It is also hypothesized that neurobehavioral abnormalities identified at two weeks of age will correlate with neurodevelopmental impairment at 18 months.

3: SPECIFIC Aim III: To determine if common genetic variations in the genes involving narcotic action contribute to the severity of NAS. A DNA sample will be obtained from all infants and analyzed for differences in 3 key genes. This will then be correlated with short-term and long-term outcomes.


Options:
A: Arm Label: Oral morphine solution; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oral morphine solution | Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: buprenorphine | Intervention Type: DRUG; Name: buprenorphine; Assigned to Arm(s): Buprenorphine | Intervention Type: DRUG; Name: Oral morphine solution; Assigned to Arm(s): Oral morphine solution
B: Arm Label: sublingual buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: sublingual buprenorphine | Arm Label: oral morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: oral morphine | Intervention Type: DRUG; Name: sublingual buprenorphine; Assigned to Arm(s): sublingual buprenorphine | Intervention Type: DRUG; Name: oral morphine; Assigned to Arm(s): oral morphine
C: Arm Label: Phenobarbital; Type: EXPERIMENTAL; Interventions: Drug: Phenobarbital | Arm Label: Chlorpromazine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chlorpromazine | Arm Label: Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine | Intervention Type: DRUG; Name: Phenobarbital; Assigned to Arm(s): Phenobarbital | Intervention Type: DRUG; Name: Chlorpromazine; Assigned to Arm(s): Chlorpromazine | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine
D: Arm Label: Neonatal Morphine Solution; Type: ACTIVE_COMPARATOR; Interventions: Drug: Neonatal Morphine Solution, Drug: Phenobarbital | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone, Drug: Phenobarbital | Intervention Type: DRUG; Name: Neonatal Morphine Solution; Assigned to Arm(s): Neonatal Morphine Solution | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Phenobarbital; Assigned to Arm(s): Methadone, Neonatal Morphine Solution

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ballistic Strength Training in Stroke: A Phase II Randomized, Controlled, Assessor Blinded Pilot Study
Brief Summary: This pilot study intends to evaluate whether stroke patients can complete ballistic strength exercises for thirty minutes, three times per week over a six week training period in addition to their existing rehabilitation program.

It will evaluate whether using ballistic training principles, is superior in improving mobility compared with usual care exercises to improve mobility and leg strength in stroke patients.

In this study there will be 15 participants per group, a total of 30 participants. The control group will receive usual care consistent with existing rehabilitation practice and literature. The experimental group will perform task specific strength training in a ballistic fashion.


Options:
A: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Other: Ballistic Strength Training | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care Physiotherapy | Intervention Type: OTHER; Name: Ballistic Strength Training; Assigned to Arm(s): Experimental | Intervention Type: OTHER; Name: Usual Care Physiotherapy; Assigned to Arm(s): Control
B: Arm Label: TheraTogs; Type: EXPERIMENTAL; Interventions: Device: TheraTogs | Arm Label: Cane walking; Type: ACTIVE_COMPARATOR; Interventions: Device: Cane walking | Intervention Type: DEVICE; Name: TheraTogs; Assigned to Arm(s): TheraTogs | Intervention Type: DEVICE; Name: Cane walking; Assigned to Arm(s): Cane walking
C: Arm Label: Sitting; Type: EXPERIMENTAL; Interventions: Behavioral: Sitting | Arm Label: Standing; Type: EXPERIMENTAL; Interventions: Behavioral: Standing | Arm Label: Walking; Type: EXPERIMENTAL; Interventions: Behavioral: Walking | Intervention Type: BEHAVIORAL; Name: Sitting; Assigned to Arm(s): Sitting | Intervention Type: BEHAVIORAL; Name: Standing; Assigned to Arm(s): Standing | Intervention Type: BEHAVIORAL; Name: Walking; Assigned to Arm(s): Walking
D: Arm Label: early mobilization; Type: EXPERIMENTAL; Interventions: Behavioral: early mobilization | Arm Label: early standard intervention; Type: OTHER; Interventions: Behavioral: early standard intervention | Intervention Type: BEHAVIORAL; Name: early mobilization; Assigned to Arm(s): early mobilization | Intervention Type: BEHAVIORAL; Name: early standard intervention; Assigned to Arm(s): early standard intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ballistic Strength Training in Stroke: A Phase II Randomized, Controlled, Assessor Blinded Pilot Study
Brief Summary: This pilot study intends to evaluate whether stroke patients can complete ballistic strength exercises for thirty minutes, three times per week over a six week training period in addition to their existing rehabilitation program.

It will evaluate whether using ballistic training principles, is superior in improving mobility compared with usual care exercises to improve mobility and leg strength in stroke patients.

In this study there will be 15 participants per group, a total of 30 participants. The control group will receive usual care consistent with existing rehabilitation practice and literature. The experimental group will perform task specific strength training in a ballistic fashion.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: Active transcranial Direct Current Stimulation / Constraint Induced Movement Therapy | Arm Label: 2; Type: SHAM_COMPARATOR; Interventions: Device: Sham transcranial Direct Current Stimulation / Constraint Induced Movement Therapy | Intervention Type: DEVICE; Name: Active transcranial Direct Current Stimulation / Constraint Induced Movement Therapy; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: Sham transcranial Direct Current Stimulation / Constraint Induced Movement Therapy; Assigned to Arm(s): 2
B: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Other: Ballistic Strength Training | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care Physiotherapy | Intervention Type: OTHER; Name: Ballistic Strength Training; Assigned to Arm(s): Experimental | Intervention Type: OTHER; Name: Usual Care Physiotherapy; Assigned to Arm(s): Control
C: Arm Label: Exercise + practice; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise, Behavioral: Practice | Arm Label: Rest + practice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Practice | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise + practice | Intervention Type: BEHAVIORAL; Name: Practice; Assigned to Arm(s): Exercise + practice, Rest + practice
D: Arm Label: Higher-intensity RT group; Type: EXPERIMENTAL; Interventions: Device: RT, Behavioral: Conventional rehabilitation (CR) | Arm Label: Lower-intensity RT group; Type: EXPERIMENTAL; Interventions: Device: RT, Behavioral: Conventional rehabilitation (CR) | Arm Label: Conventional rehabilitation (CR) group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional rehabilitation (CR) | Intervention Type: DEVICE; Name: RT; Assigned to Arm(s): Higher-intensity RT group, Lower-intensity RT group | Intervention Type: BEHAVIORAL; Name: Conventional rehabilitation (CR); Assigned to Arm(s): Conventional rehabilitation (CR) group, Higher-intensity RT group, Lower-intensity RT group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ballistic Strength Training in Stroke: A Phase II Randomized, Controlled, Assessor Blinded Pilot Study
Brief Summary: This pilot study intends to evaluate whether stroke patients can complete ballistic strength exercises for thirty minutes, three times per week over a six week training period in addition to their existing rehabilitation program.

It will evaluate whether using ballistic training principles, is superior in improving mobility compared with usual care exercises to improve mobility and leg strength in stroke patients.

In this study there will be 15 participants per group, a total of 30 participants. The control group will receive usual care consistent with existing rehabilitation practice and literature. The experimental group will perform task specific strength training in a ballistic fashion.


Options:
A: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Other: Ballistic Strength Training | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care Physiotherapy | Intervention Type: OTHER; Name: Ballistic Strength Training; Assigned to Arm(s): Experimental | Intervention Type: OTHER; Name: Usual Care Physiotherapy; Assigned to Arm(s): Control
B: Arm Label: Long term follow up program; Type: EXPERIMENTAL; Interventions: Behavioral: Long term follow up by a coordinating physiotherapist | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Intervention Type: BEHAVIORAL; Name: Long term follow up by a coordinating physiotherapist; Assigned to Arm(s): Long term follow up program | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard care
C: Arm Label: Care Management+Community Health Worker; Type: EXPERIMENTAL; Interventions: Behavioral: Care Management+Community Health Worker | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Care Management+Community Health Worker; Assigned to Arm(s): Care Management+Community Health Worker | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care
D: Arm Label: Exercise recommendation; Type: EXPERIMENTAL; Interventions: Other: Aerobic exercise | Arm Label: Aerobic exercise; Type: EXPERIMENTAL; Interventions: Other: Aerobic exercise | Intervention Type: OTHER; Name: Aerobic exercise; Assigned to Arm(s): Aerobic exercise, Exercise recommendation

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Following a small, open-label pilot study that yielded very promising results of BATD, the current study will consist of a larger, randomized control trial (n=60) that will compare BATD to Supportive Counseling in outcomes of depression, contact with positive reinforcement in the environment, treatment satisfaction, therapeutic alliance, and perceived stigma. In addition, participants' adherence rates to each of the therapies and their maintenance of clinical gains at a 1-month follow-up, will be examined.


Options:
A: Arm Label: Behavioral Activation Treatment for Depression; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Activation for Depression Treatment | Arm Label: Supportive Counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supportive Counseling | Intervention Type: BEHAVIORAL; Name: Behavioral Activation for Depression Treatment; Assigned to Arm(s): Behavioral Activation Treatment for Depression | Intervention Type: BEHAVIORAL; Name: Supportive Counseling; Assigned to Arm(s): Supportive Counseling
B: Arm Label: Exercise Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Intervention | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Wellness control | Intervention Type: BEHAVIORAL; Name: Wellness control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Physical Activity Intervention; Assigned to Arm(s): Exercise Intervention
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard hemodialysis dietary instruction | Arm Label: B; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral counseling plus PDA-based self-monitoring of diet | Intervention Type: BEHAVIORAL; Name: Standard hemodialysis dietary instruction; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Behavioral counseling plus PDA-based self-monitoring of diet; Assigned to Arm(s): B
D: Arm Label: Computer Use; Type: EXPERIMENTAL; Interventions: Other: Computer Use | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Computer Use; Assigned to Arm(s): Computer Use

Answer: A